BGM Group Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BGM research report →
Companywww.bgm.ltd
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications.
- CEO
- Chen Xin
- IPO
- 2003
- Employees
- 298
- HQ
- Chengdu, CN
Price Chart
Valuation
- Market Cap
- $58.58M
- P/E
- -1.46
- P/S
- 2.33
- P/B
- 0.05
- EV/EBITDA
- 55.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 16.39%
- Op Margin
- -2.25%
- Net Margin
- -5.75%
- ROE
- -3.37%
- ROIC
- -0.90%
Growth & Income
- Revenue
- $25.10M · -45.99%
- Net Income
- $-1,442,830 · 81.46%
- EPS
- $-0.20 · 81.48%
- Op Income
- $-563,771
- FCF YoY
- 0.43%
Performance & Tape
- 52W High
- $17.17
- 52W Low
- $0.26
- 50D MA
- $0.45
- 200D MA
- $4.89
- Beta
- 1.81
- Avg Volume
- 331.33K
Get TickerSpark's AI analysis on BGM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 31, 26 | ren yuehua | other | 0 |
| Mar 31, 26 | ZHAI Yaxuan | other | 0 |
| Mar 31, 26 | XU WAIHUA | other | 0 |
| Apr 28, 26 | Lou Zefei | other | 0 |
| Apr 13, 26 | ZHANG LIN (Henry) | other | 0 |
Our BGM Coverage
We haven't published any research on BGM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BGM Report →